Company Profile

Atrevida Science LLC (AKA: Atrevia Science~Claudia Maldonado Hall)
Profile last edited on: 3/18/2022      CAGE: 87PG3      UEI: U4N5BAHETDD3

Business Identifier: Active morphing blades¬ô for Wind Turbines
Year Founded
----
First Award
2019
Latest Award
2023
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

8941 Galway Terrace
Clarence Center, NY 14032
   (716) 320-0449
   mail@atrevidascience.com
   atrevidascience.com
Location: Single
Congr. District: 27
County: Erie

Public Profile

Focused on lowering the cost wind turbine energy, Atrevida is developing an active morphing blade for wind turbines targeting specifically the massive and growing offshore wind market. It is well known that efficiency and failure are plaguing this industry. The Atrevia Science approach is the development of an active morphing blade that changes its shape to optimal geometry according to the wind conditions. The product offers increased efficiency and sheds loads that are detrimental to the system. Many in the wind turbine space argue that bigger blades, static designs that are environmentally unfriendly, along with insistence on land-based installations are old paradigms. Further, employing a very different business model, Atrevida Science’s approach of an actuated blade provides active control to increase efficiency, reduce loading, and improve stability.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Claudia Maldonado -- Founder

  John Hall

  Hamid Khakpour -- Technology Director

Company News

There are no news available.